UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 402

Sortiert nach

Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor

Molecular pharmacology, 1985-10, Vol.28 (4), p.323-330

1985

Link zum Volltext

Verfügbarkeit prüfen

A standby current limited performance figure of merit for deep sub-micron CMOS

IEEE transactions on electron devices, 1997-11, Vol.44 (11), p.1888-1895

1997

Link zum Volltext
IEEE_Xplore

An Etch-stop Utilizing Selective Etching Of N-type Silicon By Pulsed Potential Anodization

Journal of microelectromechanical systems, 1992-12, Vol.1 (4), p.187-192

1992

Link zum Volltext
IEEE_Xplore

Manufacturable high performance quarter micron CMOS technology using I-line lithography and gate linewidth reduction etch process

Digest of technical papers - Symposium on VLSI Technology, 1996, p.216-217

1996

Link zum Volltext

Verfügbarkeit prüfen

High performance 0.3 mu m CMOS using I-line lithography and BARC

Digest of technical papers - Symposium on VLSI Technology, 1995, p.75-76

1995

Link zum Volltext

Verfügbarkeit prüfen

Competitive binding kinetics in ligand-receptor-competitor systems: Rate parameters for unlabeled ligands for the formyl peptide receptor

Molecular pharmacology, 1985-01, Vol.28 (3), p.323-330

1985

Link zum Volltext

Verfügbarkeit prüfen

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

The New England journal of medicine, 2018-10, Vol.379 (16), p.1519-1528

2018

Link zum Volltext

Verfügbarkeit prüfen

Test of Lepton-Flavor Universality in B→K^{}ℓ^{+}ℓ^{-} Decays at Belle

Physical review letters, 2021-04, Vol.126 (16), p.161801-161801, Article 161801

2021

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

The New England journal of medicine, 2017-11, Vol.377 (19), p.1824-1835

2017

Link zum Volltext

Verfügbarkeit prüfen

A generalizable method for remote sensing of canopy nitrogen across a wide range of forest ecosystems

Remote sensing of environment, 2008-09, Vol.112 (9), p.3511-3519

2008

Link zum Volltext

Verfügbarkeit prüfen

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

Journal of clinical oncology, 2020-11, Vol.38 (33), p.3937-3946

2020

Link zum Volltext

Verfügbarkeit prüfen

On the issue of transparency and reproducibility in nanomedicine

Nature nanotechnology, 2019-07, Vol.14 (7), p.629-635

2019

Link zum Volltext

Verfügbarkeit prüfen

Storying Survival: An Approach to Radical Healing for the Black Community

Journal of counseling psychology, 2023-04, Vol.70 (3), p.276-292

2023

Link zum Volltext

Verfügbarkeit prüfen

Modelling hollow fiber membrane modules for anesthesia gas separation

Chemical engineering science, 2018-12, Vol.191, p.479-489

2018

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

The New England journal of medicine, 2009-12, Vol.361 (23), p.2209-2220

2009

Link zum Volltext

Verfügbarkeit prüfen

Childhood Maltreatment and Anhedonic Symptoms: Test of a Dual-risk Model in Emerging Adults

Journal of interpersonal violence, 2022-05, Vol.37 (9-10), p.NP7447-NP7469

2022

Link zum Volltext

Verfügbarkeit prüfen

Do Nutrient Limitation Patterns Shift from Nitrogen Toward Phosphorus with Increasing Nitrogen Deposition Across the Northeastern United States?

Ecosystems (New York), 2012-09, Vol.15 (6), p.940-957

2012

Link zum Volltext

Verfügbarkeit prüfen

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

The Lancet (British edition), 2017-10, Vol.390 (10105), p.1853-1862

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

The New England journal of medicine, 2017-03, Vol.376 (12), p.1131-1140

2017

Link zum Volltext

Verfügbarkeit prüfen

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome

Oncogene, 2009-04, Vol.28 (15), p.1812-1820

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

The Lancet infectious diseases, 2016-10, Vol.16 (10), p.1154-1168

2016

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

The New England journal of medicine, 2015-01, Vol.372 (4), p.320-330

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 402

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(352)
Mit Volltextzugriff
(361)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(401)
Russisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Competitive binding kinetics in ligand-receptor-competitor systems. Rate parameters for unlabeled ligands for the formyl peptide receptor

A standby current limited performance figure of merit for deep sub-micron CMOS

An Etch-stop Utilizing Selective Etching Of N-type Silicon By Pulsed Potential Anodization

Manufacturable high performance quarter micron CMOS technology using I-line lithography and gate linewidth reduction etch process

High performance 0.3 mu m CMOS using I-line lithography and BARC

Competitive binding kinetics in ligand-receptor-competitor systems: Rate parameters for unlabeled ligands for the formyl peptide receptor

Effect of Aspirin on All-Cause Mortality in the Healthy Elderly

Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

Test of Lepton-Flavor Universality in B→K^{}ℓ^{+}ℓ^{-} Decays at Belle

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

A generalizable method for remote sensing of canopy nitrogen across a wide range of forest ecosystems

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial

Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma

On the issue of transparency and reproducibility in nanomedicine

Storying Survival: An Approach to Radical Healing for the Black Community

Modelling hollow fiber membrane modules for anesthesia gas separation

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Childhood Maltreatment and Anhedonic Symptoms: Test of a Dual-risk Model in Emerging Adults

Do Nutrient Limitation Patterns Shift from Nitrogen Toward Phosphorus with Increasing Nitrogen Deposition Across the Northeastern United States?

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

Alveolar epithelial glycocalyx degradation mediates surfactant dysfunction and contributes to acute respiratory distress syndrome

Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome

Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study

Nivolumab in Previously Untreated Melanoma without BRAF Mutation

Aktive Filter

Suchergebnisse filtern